TW201611830A - Pharmaceutical formulation for reducing bladder spasms and method of use thereof - Google Patents

Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Info

Publication number
TW201611830A
TW201611830A TW104114896A TW104114896A TW201611830A TW 201611830 A TW201611830 A TW 201611830A TW 104114896 A TW104114896 A TW 104114896A TW 104114896 A TW104114896 A TW 104114896A TW 201611830 A TW201611830 A TW 201611830A
Authority
TW
Taiwan
Prior art keywords
bladder spasms
pharmaceutical formulation
reducing bladder
effective amount
reducing
Prior art date
Application number
TW104114896A
Other languages
Chinese (zh)
Other versions
TWI618535B (en
Inventor
David A Dill
Original Assignee
Wellesley Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/495,134 external-priority patent/US20150010599A1/en
Application filed by Wellesley Pharmaceuticals Llc filed Critical Wellesley Pharmaceuticals Llc
Publication of TW201611830A publication Critical patent/TW201611830A/en
Application granted granted Critical
Publication of TWI618535B publication Critical patent/TWI618535B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods and compositions for reducing bladder spasms are disclosed. The methods comprise administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of acetaminophen and an effective amount of at least one non-steroidal anti-inflammatory drug (NSAID). In another embodiment, a method for reducing bladder spasms comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of at least one prostaglandin (PG) pathway inhibitor, wherein the at least one PG pathway inhibitor is not acetaminophen or an NSAID.
TW104114896A 2014-09-24 2015-05-11 Pharmaceutical formulation for reducing bladder spasms and method of use thereof TWI618535B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/495,134 2014-09-24
US14/495,134 US20150010599A1 (en) 2010-07-08 2014-09-24 Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Publications (2)

Publication Number Publication Date
TW201611830A true TW201611830A (en) 2016-04-01
TWI618535B TWI618535B (en) 2018-03-21

Family

ID=56360653

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104114896A TWI618535B (en) 2014-09-24 2015-05-11 Pharmaceutical formulation for reducing bladder spasms and method of use thereof

Country Status (2)

Country Link
AR (1) AR100515A1 (en)
TW (1) TWI618535B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112704727A (en) * 2021-01-12 2021-04-27 重庆医科大学附属第二医院 Application of terlipressin in preparation of medicine for treating dynamic ileus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006127096A2 (en) * 2005-05-20 2006-11-30 Omeros Corporation Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112704727A (en) * 2021-01-12 2021-04-27 重庆医科大学附属第二医院 Application of terlipressin in preparation of medicine for treating dynamic ileus
CN112704727B (en) * 2021-01-12 2023-05-16 重庆医科大学附属第二医院 Application of terlipressin in preparation of medicament for dynamic intestinal obstruction

Also Published As

Publication number Publication date
AR100515A1 (en) 2016-10-12
TWI618535B (en) 2018-03-21

Similar Documents

Publication Publication Date Title
CL2017000902A1 (en) Ror-gamma inhibitor dihydropyrrolopyridines
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MY196173A (en) Cot Modulators And Methods Of Use Thereof
PH12016500649A1 (en) Combinations of histone deactylase inhibitors and immunomodulatory drugs
CL2015002164A1 (en) Combined formulation of two antiviral compounds.
PH12016501790B1 (en) Pharmaceutical compositions of therapeutically active compounds
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
PH12016501788B1 (en) Pharmaceutical compositions of therapeutically active compounds
BR112016022062A8 (en) combination, pharmaceutical composition, use of a combination or a pharmaceutical composition, and pharmaceutical product
PH12016502291A1 (en) Indolizine derivatives as phosphoinositide 3-kinases inhibitors
WO2014153009A3 (en) Thiosaccharide mucolytic agents
MX2022001796A (en) Methods and compositions to inhibit symptoms associated with veisalgia.
WO2014153495A3 (en) Novel stat3 inhibitors
AU2016204294A1 (en) Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor
BR112016028518A2 (en) pharmaceutical compositions comprising dgla and use thereof
EA201892539A1 (en) PYRIDINYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION AS AOS3 Inhibitors
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
MX2016016039A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof.
ECSP15050273A (en) ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
CR20160353A (en) CHOLESTERILE ESTER TRANSFER PROTEIN INHIBITOR (CETP) AND PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
MX2017003878A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof.
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
MX2014005153A (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain.
MX2014005152A (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.
AR100729A1 (en) PHARMACEUTICAL FORMULATION TO REDUCE THE FREQUENCY OF MICTION AND METHOD FOR USE

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees